ZYXI - Zynex Inc

ZYXI - Zynex Inc

https://www.zynex.com

Recent News

Powered by Alpha Vantage

ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Zynex ( NASDAQ:ZYXI )

Benzinga • 5 days, 18 hours ago • score: -0.11

NEW YORK, Sept. 09, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zynex, Inc.

Zynex, Inc. Investors: Company Investigated by the Portnoy Law Firm - Zynex ( NASDAQ:ZYXI )

Benzinga • 1 month ago • score: -0.11

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 14, 2025 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Zynex, Inc. ( "Zynex" or "the Company" ) ZYXI investors that the firm has initiated an investigation into possible securities ...

ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Zynex ( NASDAQ:ZYXI )

Benzinga • 1 month ago • score: -0.11

NEW YORK, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zynex, Inc.

Zynex Inc. ( ZYXI ) Reports Q2 Loss, Misses Revenue Estimates

Zacks Commentary • 1 month, 2 weeks ago • score: 0.04

Zynex (ZYXI) delivered earnings and revenue surprises of -60.00% and -17.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Zynex ( NASDAQ:ZYXI )

Benzinga • 2 months ago • score: -0.11

NEW YORK, July 10, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zynex, Inc.

Zynex, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; May 19, 2025 Deadline to file Lead Plaintiff Motion - Zynex ( NASDAQ:ZYXI )

Benzinga • 3 months, 3 weeks ago • score: -0.28

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 19, 2025 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Zynex, Inc. ( "Zynex" or the "Company" ) ZYXI investors of a class action representing investors that bought securities between ...

DEADLINE ALERT for ZYXI, PPTA, and UCTT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Perpetua Resources ( NASDAQ:PPTA ) , Ultra Clean Hldgs ( NASDAQ:UCTT )

Benzinga • 3 months, 3 weeks ago • score: -0.21

LOS ANGELES, May 19, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Zynex, Inc. designs, manufactures and markets medical devices to treat chronic and acute pain; and activating and exercising muscles for rehabilitation purposes with electrical stimulation. The company is headquartered in Englewood, Colorado.

52W High

$9.42

52W Low

$1.23

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.02

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

16.61

EV/EBITDA (<8 favorable)

20.66

EV/Revenue (<3 favorable)

0.69

P/S (TTM) (<3 favorable)

0.31

P/B (<3 favorable)

35.80

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

48.31%

Institutions (25–75% balanced)

18.35%

Shares Outstanding

30,297,400

Float

15,700,400

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

2022-01-05

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

144,808,000

Gross Profit (TTM)

109,620,000

EPS (TTM)

-0.93

Profit Margin (>10% good)

-0.20%

Operating Margin (TTM) (higher better)

-0.46%

ROE (TTM) (>15% strong)

-1.68%

EPS YoY (Quarterly) (>10% good)

-0.30

Revenue YoY (Quarterly) (>8% good)

-0.55

Momentum

Value

N/A

Previous

N/A

Trend

—

Signal Cross

No cross

As of

—